KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boeing (BA) Cash & Equivalents (2016 - 2025)

Boeing (BA) has disclosed Cash & Equivalents for 17 consecutive years, with $10.9 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 20.87% to $10.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 billion through Dec 2025, down 20.87% year-over-year, with the annual reading at $10.9 billion for FY2025, 20.87% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $10.9 billion at Boeing, up from $6.2 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $14.6 billion in Q4 2022, with the low at $6.2 billion in Q3 2025.
  • Average Cash & Equivalents over 5 years is $9.6 billion, with a median of $9.9 billion recorded in 2021.
  • The sharpest move saw Cash & Equivalents plummeted 58.63% in 2021, then soared 81.5% in 2022.
  • Over 5 years, Cash & Equivalents stood at $8.1 billion in 2021, then skyrocketed by 81.5% to $14.6 billion in 2022, then fell by 13.16% to $12.7 billion in 2023, then increased by 8.75% to $13.8 billion in 2024, then decreased by 20.87% to $10.9 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $10.9 billion, $6.2 billion, and $7.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.